查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2008719

生物感测器市场报告：按产品、技术、应用、最终用途和地区划分（2026-2034 年）

Biosensors Market Report by Product, Technology, Application, End Use, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 147 Pages | 商品交期: 2-3个工作天内

价格

2025年全球生物感测器市场规模达331亿美元。展望未来，IMARC集团预测，到2034年，该市场规模将达到589亿美元，2026年至2034年的复合年增长率（CAGR）为6.42%。北美地区凭藉其完善的医疗保健基础设施、强大的研发投入、对个人化医疗的高需求以及众多大型生物感测器製造商和技术公司的存在，正引领着市场成长。技术进步、慢性病盛行率上升、即时检测（POC​​T）需求成长、在医疗保健、食品和环境监测等领域的应用不断扩展、政府倡议、研发投入、可穿戴生物感测器的出现以及对精准医疗和个人化治疗方法的日益关注，都是推动市场成长的因素。

市场规模及预测：

  • 预计到 2025 年，生物感测器市场规模将达到 331 亿美元。
  • 预计到 2034 年，该市场规模将达到 589 亿美元，2026 年至 2034 年的复合年增长率为 6.42%。

主要部分：

  • 产品：非穿戴式生物感测器因其在临床诊断、医学检测和实验室应用中的广泛使用而占据最大的市场份额。它们具有高精度、多功能性，并且易于整合到现有医疗系统中，无需持续佩戴即可实现高效的疾病监测和即时诊断。
  • 技术方面：电化学生物感测器因其高灵敏度、低成本、易用性和快速响应时间而占据最大的市场份额。其可靠的性能、便携性以及检测多种分析物的能力使其广泛应用于各种领域，包括血糖监测和环境检测。
  • 应用领域：随着糖尿病在全球范围内的日益流行，血糖值监测已成为最大的应用领域。随着对连续血糖监测需求的成长，电化学生物感测器提供了一种经济高效的解决方案。这些设备能够提供准确的即时测量结果，帮助患者管理自身病情并预防併发症。
  • 最终用途：即时检测因其便捷、快速以及能够在患者照护现场立即提供检测结果而占据市场主导地位。这减少了患者前往检查室的次数，加快了诊断速度，并改善了患者的治疗效果。它在紧急情况和偏远地区尤为有利。
  • 区域：北美凭藉其完善的医疗保健基础设施、对创新医疗设备日益增长的需求、大量的研发投入以及众多主要生物感测器製造商的存在，引领着市场发展。此外，优惠的医保报销政策和庞大的老龄人口也巩固了该地区的市场主导地位。

主要企业：

  • 生物感测器市场的主要企业包括雅培实验室、Agamatrix（WaveForm Technologies Inc.）、杜邦公司、罗氏公司、通用电气公司、LifeScan（Platinum Equity LLC）、Medtronic、Nova Biomedical公司、PHC Holdings公司、西门子公司和赛默飞世尔科技公司。

市场成长的主要驱动因素：

  • 慢性病盛行率上升：慢性病盛行率的上升正在推动生物感测器市场的成长。这是因为持续监测对于症状管理和早期发现至关重要。生物感测器能够即时追踪关键健康参数，从而改善慢性病患者的生活品质并预防併发症。
  • 生物製程监测技术的进步：生物製程监测技术的改进，尤其是在生物技术和製药领域，正在推动市场成长。对生物反应器过程的即时监测提高了细胞培养、发酵和生物技术应用的准确性和效率。先进的生物感测器能够检测低浓度分子，从而优化生产和生物製程管理。
  • 技术进步：诸如自发光生物感测器和量子非弹性电子隧道等技术进步正在提升生物感测器检测极低浓度生物分子的能力。这些创新实现了无标定即时诊断，提高了检测精度，并拓展了生物感测器在医疗保健、环境监测和现场诊断等领域的应用范围。
  • 穿戴式健康设备的成长：配备先进生物感测器的可穿戴设备的日益普及正在对市场产生积极影响。这些设备能够持续监测心率和血糖值等生命体征，提供便利的即时健康数据，尤其对慢性病患者更是如此。
  • 政府财政支持：政府对研发的承诺和财政支持对于推动市场成长至关重要。这些投资旨在使生物感测器具备功能性、准确性和可负担性，而公私合营正在加速个人化医疗、疾病监测和诊断领域的发展。
  • 健康意识的提升：公众健康意识的增强推动了生物感测器设备的普及。随着人们越来越积极主动地管理自身健康，对能够监测生命征象、早期发现慢性疾病并支持预防医学的个人健康追踪设备的需求也日益增长。

未来展望：

  • 强劲成长前景：生物感测器市场正经历强劲成长，这主要得益于技术进步、医疗需求成长以及对个人化医疗日益增长的需求。穿戴式和非侵入式感测器的创新，以及人们对慢性病管理意识的提高，共同创造了全球良好的市场前景。
  • 市场发展：生物感测器市场正随着小型化、与行动医疗平台整合以及精度提升等技术的进步而快速发展。这些进步正在扩大生物感测器的应用范围，使其涵盖医疗诊断和环境监测等领域，从而为市场成长和创新创造新的机会。

随着世界人口老化，人们对可靠有效的医疗保健方案的需求日益增长。生物感测器对于疾病监测、慢性病（如糖尿病）管理以及早期诊断至关重要。随着个人化医疗和预防医学的兴起，生物感测器在即时监测健康状况和改善患者预后方面变得不可或缺。此外，人们也需要非侵入性监测方法，例如穿戴式生物感测器。这些设备无需侵入性操作即可进行连续监测，从而提高患者的舒适度和治疗依从性。这一趋势在慢性病（如糖尿病）的管理中尤其有利，使患者无需在皮肤上扎针即可监测血糖值。此外，政府和私人机构都在为生物感测器技术的研究倡议提供大量资金。由于医疗技术的创新，特别是旨在改善公众健康状况的医疗保健解决方案的投资，生物感测器领域正在取得显着进展。这些资金支持正在加速创新生物感测器应用的发展。

生物感测器市场的发展趋势：

慢性病增多

糖尿病、心臟病和呼吸系统疾病等慢性病发病率的上升推动了生物感测器市场的成长。持续监测对于控制症状、预防併发症和提高患者的生活品质至关重要。生物感测器提供了一种切实可行的方法，能够即时监测关键健康指标并支持早期发现异常。例如，糖尿病患者使用持续血糖监测仪来控制血糖值并调整胰岛素剂量。同样，心臟病患者依靠生物感测器来追踪心率并识别心律不整。随着全球慢性病盛行率的上升，对能够提供持续健康监测的生物感测器的需求也不断增长。 2025年，Ottai推出了一款由人工智慧驱动的可穿戴生物感测器，旨在持续监测和管理慢性病。该设备利用即时生物标记追踪、语音启动记录和人工智慧分析，提供个人化的生活方式提案。它还可以与医疗保健应用程式集成，提供扩充性的、以患者为中心的护理解决方案。

生物过程监测的进展

生物过程监测技术的进步正在推动市场成长，尤其是在生物技术和製药行业。即时监测生物反应器过程对于维持细胞培养、发酵和各种生物技术应用的品质、准确性和效率至关重要。具备先进功能的生物感测器，例如能够检测极低浓度的关键分子，正在提高生物製程的精确度。这些感测器有助于优化培养基製备和生物製程控制，在製药、生物技术和替代蛋白等领域的规模化生产中发挥关键作用。顺应这一趋势，The Cultivated B 于 2025 年推出了一款由人工智慧驱动的多通道生物感测器，用于即时监测生物反应器过程，从而提高细胞培养和发酵的准确性和效率。这些线上感测器能够检测关键分子的超低浓度，并利用人工智慧优化培养基成分和生物过程控制。这项创新技术支持生物技术、製药和替代蛋白质领域的规模化应用。

生物感测器灵敏度和小型化方面的创新

技术进步，例如自发光生物感测器的开发和量子非弹性电子穿隧效应的应用，正在提升生物感测器检测极低浓度生物分子（低至皮克级）的能力。这些进步使得无标定即可进行即时诊断，并能快速获得高准确度和结果。开发高灵敏度、小型化和便携式设备的能力拓展了生物感测器的应用范围，使其能够应用于包括医疗和环境监测在内的各个领域。随着生物感测器的效率和多功能性不断提高，其在照护现场诊断和现场监测中的应用日益广泛，加速了生物感测器技术在医疗和工业领域的融合。 2025年，瑞士洛桑联邦理工学院（EPFL）的科学家开发了世界上首个利用量子非弹性电子穿隧效应的自发光生物感测器。此感测器无需外部光源即可在单一晶片上实现发光和检测。这种小型化、超灵敏的设备能够侦测皮克级的生物分子，使其成为即时、无标定诊断的理想选择。这项创新技术可望实现扩充性、携带式生物感测器，应用于医疗和环境领域。

生物感测器市场成长要素：

穿戴式装置的广泛应用

智慧型手錶、健身追踪器和健康监测手环等穿戴式装置的日益普及，为市场带来了良好的前景。这些设备配备了先进的生物感测器，使用户能够持续监测心率、血糖值和血氧饱和度等生命体征，从而更有效地管理自身健康。穿戴式装置对于慢性病患者或註重健康改善的人尤其有用，它们无需定期就医即可提供便利的即时健康资讯。除了对个人化健康管理的需求外，穿戴式科技的进步，例如电池续航力和感测器精度的提升，也不断拓展其应用范围。 2024年，Biolinq成功资金筹措5,800万美元，用于改进其穿戴式皮内葡萄糖生物感测器。该感测器透过植入皮下的微型感测器追踪血糖值和活动水平。这项突破性设备旨在简化代谢健康监测，凸显了穿戴式装置在个人化医疗领域日益增长的重要性。

政府措施和财政援助

政府计画和研发资金支持是推动生物感测器市场扩张的关键因素。鑑于生物感测器技术在医疗保健和环境监测领域的重要性，许多政府机构正投入大量资源促进该领域的创新。这些投资旨在提升生物感测器的功能性、准确性和成本效益，从而促进其在各种应用中的使用。此外，公私合作对于个人化医疗、疾病监测和即时诊断等领域生物感测器的发展至关重要。一个值得关注的例子是宾州州立大学于2024年10月宣布的一项150万美元的美国国家科学基金会（NSF）津贴，该拨款旨在开发人工智慧设计的生物感测器，用于识别神经传导物质等分子。这项由伊达·埃布拉希米教授主导的计画涵盖了K-12 STEM教育推广、本科生研究和产业合作，凸显了学术界、产业界和政府为加速生物感测器发展而开展的合作努力。

人们越来越关注健康和保健

公众健康意识的不断提高是推动生物感测器设备普及的关键因素。随着人们越来越积极主动地管理自身健康，对能够追踪健康状况的设备的需求也日益增长。越来越多的人希望监测心率、血糖值和血压等关键指标，以改善健康状况并预防疾病。这种自我监测的趋势尤其受到早期发现糖尿病和高血压等慢性疾病需求的推动。健身追踪器和智慧型手錶等设备能够提供即时健康信息，并提供有关整体健康状况的重要见解。顺应这一趋势，雅培公司于2024年在美国推出了Lingo，这是一款商用连续血糖监测（CGM）生物感测器，此前该产品已于6月获得美国食品药物管理局（FDA）的核准。 Lingo基于FreeStyle Libre技术开发，可为非胰岛素使用者提供即时血糖值追踪、健康洞察和习惯改善指导。在预防医学意识不断增强的背景下，生物感测器市场持续成长，使人们能够有效管理自身健康。

目录

第一章：序言

第二章：调查方法

  • 调查目的
  • 相关利益者
  • 数据来源
    • 主要讯息
    • 二手资讯
  • 市场估值
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章执行摘要

第四章：引言

第五章：全球生物感测器市场

  • 市场概览
  • 市场表现
  • 新冠疫情的影响
  • 市场预测

第六章 市场区隔：依产品划分

  • 穿戴式生物感测器
  • 非穿戴式生物感测器

第七章 市场区隔：依技术划分

  • 电化学生物感测器
  • 光学生物感测器
  • 压电感测器
  • 热生物感测器
  • 奈米机械生物感测器
  • 其他的

第八章 市场区隔：依应用领域划分

  • 血糖测试
  • 胆固醇检测
  • 血气分析
  • 妊娠测试
  • 药物发现
  • 传染病检查
  • 其他的

第九章 市场区隔：依最终用途划分

  • 即时检测
  • 居家医疗诊断
  • 研究所
  • 安全与生物防御
  • 其他的

第十章 市场区隔：依地区划分

  • 北美洲
    • 我们
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

第十一章 SWOT 分析

第十二章：价值链分析

第十三章：波特五力分析

第十四章：价格分析

第十五章 竞争格局

  • 市场结构
  • 主要企业
  • 主要企业简介
    • Abbott Laboratories
    • AgaMatrix Inc.（WaveForm Technologies Inc）
    • DuPont de Nemours Inc.
    • F. Hoffmann-La Roche AG
    • General Electric Company
    • LifeScan Inc.（Platinum Equity LLC）
    • Medtronic PLC
    • Nova Biomedical Corporation
    • PHC Holdings Corporation
    • Siemens AG
    • Thermo Fisher Scientific Inc.
Product Code: SR112026A4130

The global biosensors market size reached USD 33.1 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 58.9 Billion by 2034, exhibiting a growth rate (CAGR) of 6.42% during 2026-2034. North America leads the market attributed to robust healthcare infrastructure, strong investment in research operations, high demand for personalized medicine, and the presence of leading biosensor manufacturers and tech companies. Technological advancements, rising prevalence of chronic diseases, increasing demand for point-of-care testing (POCT), the expanding applications in healthcare, food, and environmental monitoring, government initiatives, investments in research and development (R&D), emergence of wearable biosensors, and the growing focus on precision medicine and personalized treatment approaches are some of the factors favoring the market growth.

MARKET SIZE & FORECASTS:

  • Biosensors market was valued at USD 33.1 Billion in 2025.
  • The market is projected to reach USD 58.9 Billion by 2034, at a CAGR of 6.42% from 2026-2034.

DOMINANT SEGMENTS:

  • Product: Non-wearable biosensors hold the biggest market share due to their widespread use in clinical diagnostics, medical testing, and laboratory applications. They offer high accuracy, versatility, and ease of integration into existing healthcare systems, enabling efficient disease monitoring and real-time diagnostics without requiring constant wear.
  • Technology : Electrochemical biosensors account for the largest market share owing to their high sensitivity, low cost, ease of use, and fast response times. They are widely used in various applications like glucose monitoring and environmental testing because of their reliable performance, portability, and ability to detect a wide range of analytes.
  • Application : Blood glucose testing represents the largest segment because of the growing prevalence of diabetes worldwide. With the need for continuous glucose monitoring, electrochemical biosensors offer a cost-effective and efficient solution. This device provides real-time, accurate measurements, helping individuals manage their condition and avoid complications.
  • End Use : Point of care testing dominates the market attributed to its convenience, speed, and ability to provide immediate results at the site of patient care. It reduces the need for laboratory visits, enables faster diagnosis, improves patient outcomes, and is especially beneficial in emergency situations and remote areas.
  • Region: North America dominates the market accredited to robust healthcare infrastructure, growing demand for innovative medical devices, significant investments in research operations, and the presence of leading biosensor manufacturers. Additionally, favorable reimbursement policies and a large aging population further support the market dominance of the region.

KEY PLAYERS:

  • The leading companies in biosensors market include Abbott Laboratories, AgaMatrix Inc. (WaveForm Technologies Inc), DuPont de Nemours Inc., F. Hoffmann-La Roche AG, General Electric Company, LifeScan Inc. (Platinum Equity LLC), Medtronic PLC, Nova Biomedical Corporation, PHC Holdings Corporation, Siemens AG, and Thermo Fisher Scientific Inc.

KEY DRIVERS OF MARKET GROWTH:

  • Growing Prevalence of Chronic Illnesses: The rising prevalence of chronic illnesses is driving the biosensors market as continuous monitoring becomes essential for symptom management and early detection. Biosensors enable real-time tracking of critical health parameters, improving the quality of life and preventing complications in patients with chronic conditions.
  • Bioprocess Monitoring Advancements: Improvements in bioprocess monitoring, particularly in biotechnology and pharmaceuticals, is propelling the market growth. Real-time monitoring of bioreactor processes improves the accuracy and effectiveness of cell culture, fermentation, and biotechnological applications. Advanced biosensors enable the detection of low molecule concentrations, optimizing production and bioprocess management.
  • Improvements in Technology: Technological advancements, such as self-illuminating biosensors and quantum inelastic electron tunneling, are enhancing biosensors' ability to detect biomolecules at extremely low concentrations. These innovations enable label-free, real-time diagnostics, improving accuracy and expanding biosensors' applications in healthcare, environmental monitoring, and on-site diagnostics.
  • Growth of Wearable Health Devices: The growing adoption of wearable devices equipped with advanced biosensors is positively influencing the market. These devices enable continuous observation of vital signs like heart rate and glucose levels, offering convenience and real-time health data, especially for individuals with chronic conditions.
  • Financial Government Support: Government initiatives and financial support for research and development (R&D) are crucial for driving the growth of the market. These investments aim to improve biosensor functionality, accuracy, and affordability, while public-private collaborations accelerate advancements in personalized medicine, disease monitoring, and diagnostics.
  • Awareness about Health and Wellness: Growing public awareness about health and wellness is driving the adoption of biosensor-enabled devices. As individuals become more proactive about their health, there is a rise in the demand for personal health tracking devices to monitor vital signs and identify chronic conditions early, supporting preventive care.

FUTURE OUTLOOK:

  • Strong Growth Outlook : The biosensors market is experiencing a strong growth owing to improvements in technology, growing healthcare needs, and rising demand for personalized medicine. Innovations in wearable and non-invasive sensors, along with growing awareness about chronic disease management, are offering a favorable market outlook globally.
  • Market Evolution : The biosensors market is evolving with rapid technological advancements, such as miniaturization, integration with mobile health platforms, and improved accuracy. These developments are broadening the range of applications, such as medical diagnostics and environmental monitoring, creating new opportunities for market growth and innovation.

With the aging global population, there is a rise in the demand for dependable and effective healthcare options. Biosensors are essential for disease monitoring, chronic condition management, such as diabetes, and facilitating early diagnosis. As personalized and preventive healthcare gains attention, biosensors are becoming essential for monitoring health in real-time, enhancing patient results. In addition, non-invasive monitoring methods, like those employed in wearable biosensors, are sought after. These devices provide the benefit of ongoing monitoring without requiring invasive methods, enhancing patient comfort and adherence. This trend is especially advantageous for handling chronic illnesses, such as diabetes, enabling patients to track glucose levels without needing to puncture their skin. Apart from this, both governments and private organizations are significantly funding research initiatives in biosensor technologies. Investment in medical technology innovation, particularly in healthcare solutions aimed at enhancing public health outcomes, are resulting in substantial progress in biosensors. This financial assistance fosters the creation of innovative biosensor applications.

BIOSENSORS MARKET TRENDS:

Increasing Prevalence of Chronic Diseases

The rising occurrence of chronic illnesses, like diabetes, heart diseases, and breathing disorders, is contributing to the growth of the biosensors market. Continuous monitoring is essential for managing symptoms, preventing complications, and enhancing patients' quality of life under these conditions. Biosensors offer a practical approach by facilitating instant monitoring of essential health indicators, which aids in the prompt identification of abnormalities. For instance, individuals with diabetes utilize continuous glucose monitors to oversee blood sugar levels and modify insulin amounts. Likewise, people with cardiac issues depend on biosensors to track heart rate and identify irregular rhythms. With the growing prevalence of chronic illnesses worldwide, the need for biosensors that provide continuous health monitoring is escalating. In 2025, Ottai launched its AI-powered wearable biosensor designed for continuous monitoring and management of chronic diseases. The device uses real-time biomarker tracking, voice-activated logging, and AI-driven insights to deliver personalized lifestyle recommendations. It integrates with health apps to offer a scalable, patient-centric care solution.

Advancements in Bioprocess Monitoring

Improvements in bioprocess monitoring are impelling the growth of the market, especially in the biotechnology and pharmaceutical industries. Real-time observation of bioreactor processes is crucial for maintaining the quality, precision, and effectiveness of cell culture, fermentation, and various biotechnological applications. Biosensors with sophisticated features, including identifying extremely low levels of important molecules, are improving the accuracy of bioprocesses. These sensors facilitate the optimization of media formulation and bioprocess management, vital for increasing production in sectors, such as pharmaceuticals, biotechnology, and alternative proteins. In line with this trend, in 2025, The Cultivated B launched AI-driven multi-channel biosensors for real-time monitoring of bioreactor processes, enhancing accuracy and efficiency in cell culture and fermentation. These inline sensors detect ultra-low concentrations of key molecules and use AI to optimize media formulation and bioprocess control. The innovation supports scalable applications across biotech, pharma, and alternative proteins.

Innovation in Biosensor Sensitivity and Miniaturization

Technological progress, including the creation of self-illuminating biosensors and the application of quantum inelastic electron tunneling, is improving the capacity of biosensors to identify biomolecules at remarkably low concentrations, even down to the picogram level. These advancements allow for instantaneous, label-free diagnostics, providing excellent accuracy and quicker outcomes. The capacity to develop highly sensitive, small, and portable devices enhances the possible uses of biosensors, making them applicable across various sectors, such as healthcare and environmental monitoring. With the growing efficiency and versatility of biosensors, their application in point-of-care diagnostics and on-site monitoring is rising, enhancing the integration of biosensor technology in medical and industrial fields. In 2025, scientists at EPFL developed the first self-illuminating biosensor using quantum inelastic electron tunneling, enabling light generation and detection on a single chip without external light sources. This compact, ultra-sensitive device detects biomolecules at picogram levels, ideal for real-time, label-free diagnostics. The innovation promises scalable, handheld biosensors for medical and environmental applications.

BIOSENSORS MARKET GROWTH DRIVER:

Increasing Adoption of Wearable Devices

The growing use of wearable gadgets like smartwatches, fitness trackers, and health-monitoring bands is offering a favorable market outlook. These gadgets, equipped with sophisticated biosensors, allow users to consistently monitor vital signs like heart rate, glucose levels, and oxygen saturation, enhancing their ability to manage health more efficiently. Wearable devices are especially useful for people with chronic illnesses or those prioritizing wellness, providing convenience and immediate health information without the need for regular doctor appointments. The need for tailored health tracking, along with enhancements in wearable tech, such as better battery longevity and sensor precision, is broadening their application. In 2024, Biolinq secured $58 million to enhance its wearable intradermal glucose biosensor, which tracks glucose levels and activity through microsensors placed under the skin. This groundbreaking gadget aimed to streamline metabolic health monitoring, emphasizing the increasing importance of wearables in individualized healthcare.

Government Initiatives and Funding

Government programs and financial support for research and development (R&D) are essential elements propelling the expansion of the biosensors market. Acknowledging the significance of biosensor technologies for healthcare and environmental monitoring, numerous governing bodies are dedicating substantial resources to foster innovation in this area. These investments aim to enhance biosensor functionality, increase precision, and reduce costs, thereby facilitating broader accessibility for various applications. Furthermore, collaborations between the public and private sectors are crucial for advancing biosensors in personalized medicine, disease monitoring, and point-of-care diagnostics. A notable example is Penn State's announcement in October 2024 of a $1.5 million NSF grant aimed at developing AI-designed biosensors for identifying molecules, such as neurotransmitters. Directed by Professor Aida Ebrahimi, the initiative encompassed K-12 STEM outreach, undergraduate research, and partnerships with industry, highlighting the collective endeavor of academia, industry, and government to promote biosensor advancements.

Rising Awareness about Health and Wellness

The growing public awareness about health and wellness is a key factor driving the adoption of biosensor-enabled devices. As individuals take more initiative regarding their health, there is an increase in the need for personal health tracking devices. More people are becoming interested in monitoring essential indicators, like heart rate, glucose levels, and blood pressure, to improve their health and prevent medical problems. This transition towards self-monitoring is especially driven by the need for early identification of chronic illnesses such as diabetes and hypertension. Gadgets such as fitness trackers and smartwatches provide instant health information, offering crucial insights into overall well-being. In line with this trend, in 2024, Abbott launched Lingo, its over-the-counter continuous glucose monitoring (CGM) biosensor in the US, following FDA clearance in June. Built on FreeStyle Libre tech, Lingo offered real-time glucose tracking, health insights, and habit coaching for non-insulin users. With increased awareness of preventive care, the biosensor market continues to grow, enabling individuals to manage their health effectively.

BIOSENSORS INDUSTRY SEGMENTATION:

Breakup by Product:

  • Wearable Biosensors
  • Non-Wearable Biosensors

The wearable biosensors segment is driven by the increasing demand for continuous health monitoring and personalized medicine. Consumers are increasingly adopting wearable devices such as smartwatches and fitness trackers that incorporate biosensors to monitor vital signs, physical activity, and other health metrics in real-time. Advances in sensor technology, miniaturization, and wireless connectivity have enhanced the functionality and accuracy of wearable biosensors, making them more attractive to users. Additionally, the growing prevalence of chronic diseases and the aging population are fueling the need for remote patient monitoring and early detection of health issues, further boosting the adoption of wearable biosensors. The integration of biosensors with smartphones and other portable devices facilitates seamless data transmission and analysis, providing users and healthcare providers with valuable insights for managing health and wellness.

The non-wearable biosensors segment is driven by the increasing applications in medical diagnostics, environmental monitoring, and food safety. In medical diagnostics, non-wearable biosensors are widely used for detecting various biomarkers, pathogens, and diseases, offering rapid, accurate, and cost-effective solutions for clinical and laboratory settings. Environmental monitoring applications leverage non-wearable biosensors to detect pollutants, toxins, and other harmful substances in air, water, and soil, contributing to public health and safety. In the food industry, non-wearable biosensors are utilized for quality control and safety assurance by detecting contaminants and ensuring compliance with regulatory standards. The rising awareness about the importance of early disease detection, environmental protection, and food safety is driving the demand for non-wearable biosensors.

Breakup by Technology:

  • Electrochemical Biosensors
  • Optical Biosensors
  • Piezoelectric Biosensors
  • Thermal Biosensors
  • Nanomechanical Biosensors
  • Others

The electrochemical biosensors segment is driven by the increasing demand for highly sensitive and selective detection methods in medical diagnostics, environmental monitoring, and food safety. The ability of electrochemical biosensors to provide rapid, accurate, and cost-effective analysis makes them highly desirable across various applications. Advances in nanotechnology and materials science have further enhanced their performance, enabling the development of miniaturized and portable devices. Additionally, the rising prevalence of chronic diseases, such as diabetes, necessitates the widespread use of electrochemical biosensors for continuous glucose monitoring, thereby fueling market growth.

The optical biosensors segment is driven by the increasing need for high-throughput and label-free detection methods in research, clinical diagnostics, and environmental monitoring. Optical biosensors offer exceptional sensitivity and specificity, making them ideal for detecting a wide range of analytes, including biomolecules, pathogens, and pollutants. Advances in photonics and biophotonics have significantly improved the performance of optical biosensors, enabling real-time and multiplexed detection. The growing adoption of point-of-care testing and personalized medicine further boosts the demand for optical biosensors, as they provide rapid and accurate results.

The piezoelectric biosensors segment is driven by the increasing utilization in applications requiring the detection of mechanical changes due to their high sensitivity and rapid response time. These biosensors are particularly effective in detecting mass changes, making them valuable in various fields, including medical diagnostics, environmental monitoring, and industrial processes. The growing demand for portable and non-invasive diagnostic tools is fueling the adoption of piezoelectric biosensors. Furthermore, advancements in piezoelectric materials and microfabrication technologies have enhanced the performance and miniaturization of these sensors, broadening their application scope.

The thermal biosensors segment is driven by the increasing need for highly accurate and reliable temperature-based detection methods in biomedical and industrial applications. Thermal biosensors, which measure changes in temperature as a result of biochemical reactions, offer high sensitivity and specificity. They are widely used in monitoring metabolic activities, detecting pathogens, and assessing food quality. The advancements in microelectromechanical systems (MEMS) and nanotechnology have significantly improved the performance of thermal biosensors, enabling their miniaturization and integration into portable devices.

The nanomechanical biosensors segment is driven by the increasing demand for ultra-sensitive detection methods capable of measuring minute changes at the nanoscale. These biosensors leverage mechanical properties such as mass, stiffness, and surface stress to detect the presence of analytes with high precision. The growing applications in genomics, proteomics, and environmental monitoring are boosting the adoption of nanomechanical biosensors. Advances in nanotechnology and materials science have enabled the development of highly sensitive and miniaturized nanomechanical biosensors, expanding their utility in various fields.

The others segment, which includes emerging biosensor technologies such as magnetic, acoustic, and thermal biosensors, is driven by the increasing need for innovative and versatile detection methods across various industries. These biosensors offer unique advantages, including high sensitivity, specificity, and the ability to detect a wide range of analytes. The growing demand for advanced diagnostic tools, environmental monitoring systems, and food safety solutions is fueling the development and adoption of these biosensors.

Breakup by Application:

  • Blood Glucose Testing
  • Cholesterol Testing
  • Blood Gas Analysis
  • Pregnancy Testing
  • Drug Discovery
  • Infectious Disease Testing
  • Others

The glucose testing segment is driven by the increasing prevalence of diabetes worldwide, which necessitates continuous monitoring and management of blood glucose levels. Advances in biosensor technology have led to the development of more accurate, user-friendly, and cost-effective glucose monitoring devices, including continuous glucose monitors (CGMs) and self-monitoring blood glucose (SMBG) systems . These innovations have significantly improved patient compliance and outcomes by enabling real-time glucose tracking and data integration with digital health platforms.

The cholesterol testing segment is driven by the increasing incidence of cardiovascular diseases (CVDs), which are closely linked to high cholesterol levels. Early detection and management of cholesterol are crucial for preventing CVDs, leading to a higher demand for cholesterol testing biosensors. Technological advancements have resulted in more reliable and faster cholesterol testing devices, including portable and point-of-care systems that provide immediate results. Additionally, rising health consciousness, routine health check-ups, and the emphasis on preventive healthcare practices have spurred the adoption of cholesterol testing biosensors.

The blood gas analysis segment is driven by the increasing prevalence of respiratory and metabolic disorders that require precise monitoring of blood gas levels. Conditions such as chronic obstructive pulmonary disease (COPD), asthma, and renal diseases necessitate regular blood gas analysis to manage and adjust treatment plans effectively. Technological advancements have led to the development of portable and point-of-care blood gas analyzers, making it easier for healthcare providers to perform timely and accurate assessments. Furthermore, the growing adoption of these devices in emergency and critical care settings, where rapid decision-making is crucial, significantly contributes to the market's expansion.

The pregnancy testing segment is driven by the increasing demand for home-based and point-of-care diagnostic solutions that offer convenience and privacy. Technological advancements have led to the development of highly sensitive and easy-to-use pregnancy test kits that provide quick and accurate results. The rising awareness about reproductive health and the importance of early pregnancy detection for better prenatal care have also fueled the demand for these testing kits. Additionally, the increasing prevalence of planned pregnancies, coupled with the availability of affordable and accessible testing solutions, further boosts the market.

The drug discovery segment is driven by the increasing need for efficient and cost-effective methods to identify new therapeutic compounds and evaluate their efficacy and safety. Biosensors offer significant advantages in drug discovery by enabling real-time, high-throughput screening of potential drug candidates. Technological advancements have enhanced the sensitivity and specificity of biosensors, making them invaluable tools in the early stages of drug development. Additionally, the growing prevalence of chronic diseases and the demand for personalized medicine have spurred investment in biosensor technologies to accelerate drug discovery processes.

The infectious disease testing segment is driven by the increasing incidence of infectious diseases globally, necessitating rapid and accurate diagnostic solutions. Biosensors offer significant advantages in the early detection and monitoring of infectious agents, enabling timely intervention and containment. Technological advancements have led to the development of highly sensitive and portable biosensors that can detect a wide range of pathogens, including viruses, bacteria, and fungi. The ongoing threat of pandemics and emerging infectious diseases has further highlighted the importance of efficient diagnostic tools, driving investment and innovation in this segment.

The others segment, encompassing various applications such as environmental monitoring, food safety, and bioprocessing, is driven by the increasing need for real-time, accurate, and cost-effective analytical solutions. In environmental monitoring, biosensors are used to detect pollutants and contaminants, ensuring compliance with regulatory standards and safeguarding public health. In food safety, biosensors provide rapid detection of pathogens and toxins, ensuring the quality and safety of food products.

Breakup by End Use:

  • Point of Care Testing
  • Home Healthcare Diagnostics
  • Research Laboratories
  • Security and Biodefense
  • Others

The point-of-care testing (POCT) segment is driven by the increasing demand for rapid diagnostic results and the need for immediate clinical decision-making. This demand is fueled by the growing prevalence of chronic diseases such as diabetes and cardiovascular conditions, which require continuous monitoring and timely management. Technological advancements in biosensors have made these devices more portable, user-friendly, and capable of delivering accurate results quickly, enhancing their adoption in decentralized settings like clinics, emergency rooms, and even patients' homes. Additionally, the emphasis on reducing healthcare costs and improving patient outcomes has led to a shift towards point-of-care testing, allowing for faster diagnosis and treatment, thus minimizing hospital visits and stays.

The home healthcare diagnostics segment is driven by the increasing preference for convenient and accessible healthcare solutions. With the rise in the aging population and the growing burden of chronic diseases, there is a significant demand for home-based diagnostic tools that enable continuous monitoring and management of health conditions without frequent hospital visits. Advances in biosensor technology have facilitated the development of portable, easy-to-use devices that patients can operate independently, ensuring real-time health monitoring and early detection of potential health issues.

The research laboratories segment is driven by the increasing need for advanced diagnostic and analytical tools in scientific research and development. Biosensors play a crucial role in various research applications, including disease pathology, drug development, environmental monitoring, and biotechnology. The precision, sensitivity, and versatility of biosensors make them indispensable in detecting and quantifying biological molecules and pathogens, facilitating groundbreaking research and innovation. The continuous advancement in biosensor technology, including the integration of nanotechnology and microfluidics, enhances their performance, making them even more valuable in research settings.

The security and biodefense segment is driven by the increasing concerns over bioterrorism, infectious disease outbreaks, and the need for robust public safety measures. Biosensors are critical in this context due to their ability to provide rapid, accurate detection of biological and chemical threats, enabling timely response and mitigation. Governments and defense organizations invest heavily in biosensor technology to enhance national security and safeguard public health. The development of portable and real-time biosensors supports field deployment, making them essential tools for military and homeland security operations.

The others segment is driven by the increasing demand for biosensors in diverse applications beyond traditional healthcare and security uses. This includes industries such as agriculture, food and beverage, environmental monitoring, and industrial processes. In agriculture, biosensors are used for soil and crop health monitoring, ensuring optimal yield and quality. In the food and beverage industry, they are crucial for quality control and safety assurance by detecting contaminants and pathogens. Environmental monitoring applications benefit from biosensors' ability to detect pollutants and toxins in air, water, and soil, contributing to sustainability efforts.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa.

The North America regional market is driven by the increasing prevalence of chronic diseases such as diabetes and cardiovascular conditions, which necessitate advanced diagnostic tools. Additionally, the region benefits from robust healthcare infrastructure, significant investments in research and development, and the presence of major biosensor manufacturers. Government initiatives to promote personalized medicine and growing adoption of wearable biosensors for health monitoring further propel market growth. The high awareness and acceptance of new technologies among consumers and healthcare providers also contribute to the expanding biosensors market in North America.

The Europe regional market is driven by the increasing focus on early disease detection and preventive healthcare, supported by substantial government funding and initiatives. The region's strong regulatory framework ensures high standards for biosensor development and application. Additionally, Europe's aging population contributes to a rising demand for advanced diagnostic solutions, while the presence of leading biosensor companies and extensive research activities foster innovation. Growing applications in environmental monitoring and food safety, along with collaboration between academic institutions and industry players, further accelerate market growth in Europe.

The Asia Pacific regional market is driven by the increasing healthcare needs due to a large and rapidly aging population, along with the rising prevalence of chronic diseases. Economic growth and improving healthcare infrastructure in countries like China and India enhance access to advanced diagnostic tools. Governm

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Biosensors Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Wearable Biosensors
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Non-Wearable Biosensors
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Electrochemical Biosensors
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Optical Biosensors
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Piezoelectric Biosensors
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Thermal Biosensors
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Nanomechanical Biosensors
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Blood Glucose Testing
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Cholesterol Testing
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Blood Gas Analysis
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Pregnancy Testing
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Drug Discovery
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Infectious Disease Testing
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast
  • 8.7 Others
    • 8.7.1 Market Trends
    • 8.7.2 Market Forecast

9 Market Breakup by End Use

  • 9.1 Point of Care Testing
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Home Healthcare Diagnostics
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Research Laboratories
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Security and Biodefense
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Others
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 AgaMatrix Inc. (WaveForm Technologies Inc)
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 DuPont de Nemours Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 F. Hoffmann-La Roche AG
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 General Electric Company
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 LifeScan Inc. (Platinum Equity LLC)
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 Medtronic PLC
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Nova Biomedical Corporation
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9 PHC Holdings Corporation
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
    • 15.3.10 Siemens AG
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Thermo Fisher Scientific Inc.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Biosensors Market: Major Drivers and Challenges
  • Figure 2: Global: Biosensors Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Biosensors Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Biosensors Market: Breakup by Product (in %), 2025
  • Figure 5: Global: Biosensors Market: Breakup by Technology (in %), 2025
  • Figure 6: Global: Biosensors Market: Breakup by Application (in %), 2025
  • Figure 7: Global: Biosensors Market: Breakup by End Use (in %), 2025
  • Figure 8: Global: Biosensors Market: Breakup by Region (in %), 2025
  • Figure 9: Global: Biosensors (Wearable) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 10: Global: Biosensors (Wearable) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 11: Global: Biosensors (Non-Wearable) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 12: Global: Biosensors (Non-Wearable) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 13: Global: Biosensors (Electrochemical) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 14: Global: Biosensors (Electrochemical) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 15: Global: Biosensors (Optical) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 16: Global: Biosensors (Optical) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 17: Global: Biosensors (Piezoelectric) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 18: Global: Biosensors (Piezoelectric) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 19: Global: Biosensors (Thermal) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 20: Global: Biosensors (Thermal) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 21: Global: Biosensors (Nanomechanical) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 22: Global: Biosensors (Nanomechanical) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 23: Global: Biosensors (Other Technologies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 24: Global: Biosensors (Other Technologies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 25: Global: Biosensors (Blood Glucose Testing) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 26: Global: Biosensors (Blood Glucose Testing) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 27: Global: Biosensors (Cholesterol Testing) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 28: Global: Biosensors (Cholesterol Testing) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 29: Global: Biosensors (Blood Gas Analysis) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 30: Global: Biosensors (Blood Gas Analysis) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 31: Global: Biosensors (Pregnancy Testing) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 32: Global: Biosensors (Pregnancy Testing) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 33: Global: Biosensors (Drug Discovery) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 34: Global: Biosensors (Drug Discovery) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 35: Global: Biosensors (Infectious Disease Testing) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 36: Global: Biosensors (Infectious Disease Testing) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 37: Global: Biosensors (Other Applications) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 38: Global: Biosensors (Other Applications) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 39: Global: Biosensors (Point of Care Testing) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 40: Global: Biosensors (Point of Care Testing) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 41: Global: Biosensors (Home Healthcare Diagnostics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 42: Global: Biosensors (Home Healthcare Diagnostics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 43: Global: Biosensors (Research Laboratories) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 44: Global: Biosensors (Research Laboratories) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 45: Global: Biosensors (Security and Biodefense) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 46: Global: Biosensors (Security and Biodefense) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 47: Global: Biosensors (Other End uses) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 48: Global: Biosensors (Other End uses) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 49: North America: Biosensors Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 50: North America: Biosensors Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 51: United States: Biosensors Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 52: United States: Biosensors Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 53: Canada: Biosensors Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 54: Canada: Biosensors Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 55: Asia-Pacific: Biosensors Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 56: Asia-Pacific: Biosensors Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 57: China: Biosensors Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 58: China: Biosensors Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 59: Japan: Biosensors Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 60: Japan: Biosensors Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 61: India: Biosensors Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 62: India: Biosensors Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 63: South Korea: Biosensors Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 64: South Korea: Biosensors Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 65: Australia: Biosensors Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 66: Australia: Biosensors Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 67: Indonesia: Biosensors Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 68: Indonesia: Biosensors Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 69: Others: Biosensors Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 70: Others: Biosensors Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 71: Europe: Biosensors Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 72: Europe: Biosensors Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 73: Germany: Biosensors Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 74: Germany: Biosensors Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 75: France: Biosensors Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 76: France: Biosensors Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 77: United Kingdom: Biosensors Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 78: United Kingdom: Biosensors Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 79: Italy: Biosensors Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 80: Italy: Biosensors Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 81: Spain: Biosensors Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 82: Spain: Biosensors Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 83: Russia: Biosensors Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 84: Russia: Biosensors Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 85: Others: Biosensors Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 86: Others: Biosensors Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 87: Latin America: Biosensors Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 88: Latin America: Biosensors Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 89: Brazil: Biosensors Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 90: Brazil: Biosensors Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 91: Mexico: Biosensors Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 92: Mexico: Biosensors Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 93: Others: Biosensors Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 94: Others: Biosensors Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 95: Middle East and Africa: Biosensors Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 96: Middle East and Africa: Biosensors Market: Breakup by Country (in %), 2025
  • Figure 97: Middle East and Africa: Biosensors Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 98: Global: Biosensors Industry: SWOT Analysis
  • Figure 99: Global: Biosensors Industry: Value Chain Analysis
  • Figure 100: Global: Biosensors Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Biosensors Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Biosensors Market Forecast: Breakup by Product (in Million USD), 2026-2034
  • Table 3: Global: Biosensors Market Forecast: Breakup by Technology (in Million USD), 2026-2034
  • Table 4: Global: Biosensors Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 5: Global: Biosensors Market Forecast: Breakup by End Use (in Million USD), 2026-2034
  • Table 6: Global: Biosensors Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 7: Global: Biosensors Market: Competitive Structure
  • Table 8: Global: Biosensors Market: Key Players